“We’re in a Spaceship Far From Earth”: Artemis II’s Victor Glover on Perspective, Radiation and Human Health

The Artemis II crew traveled farther from Earth than any humans have been since Apollo 17, returning both striking personal reflections on deep-space isolation and a trove of biomedical data for NASA. The mission—launched April 1 and concluded April 10—served as a critical systems test of the Orion spacecraft and a rare opportunity to study human physiology outside Earth’s magnetosphere.

Crew, Mission Profile and Moments in Space

The four-person crew—Commander Reid Wiseman, Pilot Victor Glover, Christina Koch and Canadian astronaut Jeremy Hansen—rounded the far side of the Moon and shared the emotional experience of seeing Earth recede into blackness. Pilot Victor Glover told CBS News that the view underscored a shared human vulnerability: "You guys are talking to us because we’re in a spaceship really far from Earth, but you’re on a spaceship called Earth that was created to give us a place to live in the universe."

“Maybe the distance we are from you makes you think what we’re doing is special. But we’re the same distance from you...you are special in all of this emptiness.” — Victor Glover

Systems Performance and On-Board Challenges

Overall, Orion performed strongly: two planned trajectory-correction firings were canceled because the vehicle was already precisely on track, and pilots practiced manual control to provide handling data to engineers. However, the mission did encounter a practical problem when a toilet vent line froze, preventing controllers from dumping stored urine overboard. The crew used contingency collapsible urinals—specialized plastic containers—while a maneuver to warm the vent line in direct sunlight achieved only a partial remedy.

Biomedical Research Outside the Magnetosphere

For the first time since 1972, humans were operating outside the protective reach of Earth’s magnetosphere, which shields low-Earth orbiting platforms such as the International Space Station (around 250 miles altitude) from the worst of deep-space radiation. That made Artemis II a rare chance to measure effects that have been largely out of reach for decades.

NASA’s Human Research Program deployed a suite of health experiments focused on three main areas: the biological impact of deep-space radiation, physiological responses to altered gravity environments, and psychological and behavioral effects of isolation in a small spacecraft. Studies included analyses of immune biomarkers, sleep and circadian risks, cognitive and behavioral monitoring, and other physiological measures that will help build a modern baseline for missions to the Moon and eventually Mars.

Why This Matters for Future Spaceflight—and Earth

The data gathered on Artemis II will inform countermeasures, medical protocols, and diagnostics for long-duration missions where rapid return to Earth isn’t possible. That requires new approaches that let crews monitor and manage health autonomously—without a doctor or full laboratory on site.

Those same constraints exist on Earth in remote and resource-limited settings. The World Health Organization estimates roughly 4.6 billion people lack timely access to essential health services. Technologies pioneered or refined for spaceflight are being adapted for terrestrial use to deliver faster, decentralized diagnostics. One example is rHealth (rHEALTH), which is developing portable systems to analyze small, self-collected blood samples and return lab-quality biomarker results within minutes—bringing space-tested capabilities closer to point-of-care and at-home settings.

Looking Ahead

Artemis II’s results will shape planning for Artemis III and other deep-space missions and accelerate the translation of space-borne biomedical innovations to improve diagnostic access on Earth. Beyond engineering checks, the mission reaffirmed a broader human truth: from far away, Earth looks like a shared home that must be protected and understood together.